AstraZeneca Facility Visit By Sen. Gardner Highlights Industry’s Benefits
Last month, Sen. Cory Gardner (R-CO) visited AstraZeneca’s facility in Boulder, Colorado where We Work For Health and several members of AstraZeneca’s government affairs and site management teams were on hand. The visit demonstrated the positive economic impact the biopharmaceutical industry has in Colorado and across the country.
In addition to hearing remarks from AstraZeneca officials, Sen. Gardner received praise for his support of the Medicare Part D program and his stand against importing drugs from Canada. The group toured the facility and discussed the research and manufacturing process.
We Work For Health’s Sara Froelich briefed Sen. Gardner on how the biopharmaceutical industry currently supports over 62,000 jobs, pays $4 billion in wages and compensation and produces $14.5 billion in economic output. We Work For Health also provided the senator with materials about the positive value of the biopharmaceutical industry’s 1,251 clinical trials for Coloradans – and the $428.4 million footprint on the state’s health care system.
Joining We Work For Health for the event were AstraZeneca’s Head of Office for Federal Gov’t Affairs and Policy, Christie Bloomquist, Vice President and Site Head of the Boulder Manufacturing Facility, Darren Dasburg as well as Chris McDonald, Vice President of Global Biologics Colorado. The visit successfully showcased how the parts of the biopharmaceutical industry – research, development, manufacturing, and the thousands of hard-working employees – work together to benefit thousands of Coloradans and positively impact the state’s economy.Commenting is not available in this channel entry.